HPN and breast cancer: SPINT1, which is one of the Kunitz-type serine protease inhibitors and also known as HAI-1, can inhibit hepatocyte growth factor function via regulation of HGFA, matriptase, and hepsin to inhibit the migration, proliferation, and invasion of breast cancer, indicating a good prognosis [87,88,89].